Skip to main content
RAPS Euro Convergence 2026 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Learning Level: Advanced
Learning Level: Advanced
Learning Level: Expert
Learning Level: Expert
Learning Level: Foundational
Learning Level: Foundational
Learning Level: Intermediate
Learning Level: Intermediate
RAPS Focus
RAPS Focus
Networking Opportunity
Networking Opportunity
Ticketed Event
Ticketed Event
Student Focus
Student Focus

Cecil J. Nick, BSc (Hons)

Vice President (Technical)
Parexel
Ashtead, Surrey, England, United Kingdom

Cecil Nick, Vice President (Technical), at PAREXEL Consulting has been working in regulatory affairs and clinical development for over 30 years. He has particular interest in application of RWE and expertise in orphan drugs, vaccines, anti-infectives, diabetes, monoclonals and biosimilars and has engaged in scores of interactions and meetings with regulatory agencies in the EU, US, Canada, Australia, Mexico and Brazil. He has also participated extensively in Industry and International meetings on clinical development and biosimilars.

Since joining PAREXEL in February 2001 Cecil has applied his extensive scientific, drug development and regulatory experience working with pharmacologists, statisticians and therapeutic experts in supporting clients with clinical development plans and regulatory strategies for EU, US and global approval.

Cecil is a Fellow of TOPRA and has been a guest lecture at Cardiff University MSc in Clinical Research and Greenwich University MSc in Pharmaceutical Sciences courses and Biotech Module leader for the TOPRA MSc course. He was on the editorial panel of SCRIP Clinical Research and has authored many articles on regulatory and clinical development issues.

Presentation(s):

Email Cecil